H 4465 – Massachusetts
Introduced: 2021 Status: Inactive / Dead
For legislation to reduce healthcare costs by promoting non-biased prescriber education. Public Health.
Haw. Rev. Stat. §§ 328-91 through 328-106: Drug Product Selection – Hawaii
Status: Enacted Year Enacted: 1980
A pharmacy benefit manager that reimburses a contracting pharmacy for a drug on a maximum allowable cost basis shall comply with the requirements of this section. (b) The pharmacy benefit manager shall include the following …
Download
HB 1119 – Maryland
Introduced: 2020 Status: Inactive / Dead
Pharmacists – Required Notification and Authorized Substitution – Lower–Cost Drug or Device Product. Requiring a pharmacist, or the pharmacist’s designee who is under certain supervision, to inform a certain consumer of the availability of certain …
HB 1269 – Arkansas
Introduced: 2019 Status: Enacted
To Allow Pharmacists To Make Biological Product Substitutions.
HB 1562 (see companion bill SB 5601) – Washington
Introduced: 2019 Status: Inactive / Dead
CONCERNING HEALTH CARE BENEFIT MANAGEMENT. A health care benefit manager doing business as a pharmacy may not place a drug on a list unless there are at least two therapeutically equivalent multiple source drugs, or …
HB 177 – New Mexico
Introduced: 2023 Status: Inactive / Dead
House Bill 177 amends Section 26-3-3 NMSA 1978, which is entitled “Drug Product Selection Permitted – Conditions – Exception for Prohibition—Labelling,” with the effect that pharmacists would have wider authority to substitute therapeutically equivalent drugs …
HB 2811 – West Virginia
Introduced: 2019 Status: Inactive / Dead
Relating to generic drug products: A BILL to amend and reenact §30-5-12b of the Code of West Virginia, 1931, as amended, relating to generic drug products; and making the provisions retroactive.
HB 33 – Alabama
Introduced: 2019 Status: Inactive / Dead
Relating to pharmacists and the requirements for prescriptions and the dispensing of prescriptions; to amend Section 34-23-8 of the Code of Alabama 1975, to specify that, unless a physician or other practitioner indicates otherwise, a …
HB 339 – Idaho
Introduced: 2018 Status: Enacted
PHARMACY: This bill amends the Pharmacy Practice Act to enable prescriber-authorized substitution for drug products that are in the same therapeutic class and are expected to have a substantially equivalent therapeutic effect, provided certain conditions …
HB 354 (see companion bill HB 449) – Alabama
Introduced: 2019 Status: Inactive / Dead
Pharmacists, biological drug products, substitution with interchangeable biological products as defined, Sec. 34-23-8.1 added; Sec. 34-23-1 am’d.
HB 425 – Delaware
Introduced: 2018 Status: Enacted Year Enacted: 2018
This Act establishes that a contract between a pharmacy benefits manager and a pharmacy may not prohibit a pharmacy or pharmacist from doing any of the following: (1) Providing an insured with information regarding the …
HB 449 (see companion bill HB 354) – Alabama
Introduced: 2019 Status: Inactive / Dead
Pharmacists, biological drug products, substitution with interchangeable biological products as defined, Sec. 34-23-8.1 added; Sec. 34-23-1 am’d.
HB 4522 – Michigan
Introduced: 2019 Status: Inactive / Dead
Human services; medical services; Healthy Michigan; eliminate language related to cost exceeding savings. Amends sec. 105d of 1939 PA 280 (MCL 400.105d). Implement a co-pay structure that encourages use of high-value services, while discouraging low-value …
HB 5805 – Michigan
Introduced: 2018 Status: Enacted Year Enacted: 2018
Health; pharmaceuticals; generically equivalent drug products and Food and Drug Administration-designated interchangeable biological drug products; require pharmacist to charge certain amount to certain purchasers. Amends sec. 17755 of 1978 PA 368 (MCL 333.17755).
HB 664 – Maryland
Introduced: 2020 Status: Inactive / Dead
Pharmacists – Required Notification and Authorized Substitution – Lower-Costing Drugs, Medical Devices, and Biological Products. Requiring a pharmacist or a pharmacist’s designee who is under certain supervision to inform a certain consumer of the availability …
HF 1872 (see companion bill SF 2222) – Minnesota
Introduced: 2019 Status: Inactive / Dead
Prescription drug education program established, fees assessed, and money appropriated. The commissioner of human services, in collaboration with the Board of Pharmacy, the University of Minnesota Medical School, and the University of Minnesota College of …